Rennova Health Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
400.00
658.00
18,393.00
3,338.40
4,619.50
Cost of Goods Sold (COGS) incl. D&A
899.00
2,115.00
12,505.00
3,660.40
2,664.20
Gross Income
499.00
1,457.00
5,888.10
321.90
1,955.30
SG&A Expense
3,596.00
2,131.00
31,209.70
21,131.70
18,031.40
EBIT
4,095.00
3,588.00
-
-
16,076.10
Unusual Expense
9.00
10.00
16,979.50
4,354.10
12,435.30
Non Operating Income/Expense
30.00
30.00
0.30
4.50
38.30
Interest Expense
-
-
2,689.80
6,308.30
21,432.30
Pretax Income
4,056.00
3,548.00
44,990.80
23,403.40
49,905.30
Income Tax
83.00
79.00
9,028.30
778.80
1,015.70
Consolidated Net Income
3,973.00
3,469.00
35,962.50
22,624.60
50,921.00
Net Income
3,973.00
3,469.00
35,962.50
22,624.60
50,921.00
Net Income After Extraordinaries
4,018.00
3,624.00
35,962.50
12,635.60
46,644.10
Net Income Available to Common
3,928.00
3,581.00
37,589.70
32,613.70
108,539.60
EPS (Basic)
9,523.72
7,589.32
1,356.89
452.58
47.03
Basic Shares Outstanding
0.40
0.40
27.70
72.10
2,308.10
EPS (Diluted)
9,523.80
7,589.39
1,356.96
452.58
47.03
Diluted Shares Outstanding
0.40
0.40
27.70
72.10
2,308.10
EBITDA
3,919.00
3,345.00
22,571.80
19,038.60
14,360.80
Preferred Dividends
-
-
1,627.20
-
53,341.60
About Rennova Health
View Profile
